2
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Recruiting
1
Sponsor Class
NETWORK
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Conditions
Prostatic Neoplasms
14
Carcinoma, Non-Small-Cell Lung
14
Brain Neoplasms
12
Sarcoma
7
Meningioma
6
Glioma
6
Pancreatic Neoplasms
5
Lung Neoplasms
5
Esophageal Neoplasms
5
Breast Neoplasms
5
Squamous Cell Carcinoma of Head and Neck
4
Neoplasms
4
Glioblastoma
4
Carcinoma, Hepatocellular
4
Solid Tumor, Adult
3
Rhabdomyosarcoma
3
Radiation Injuries
3
Liver Neoplasms
3
Head and Neck Neoplasms
3
Chondrosarcoma
3
Uterine Cervical Neoplasms
2
Thymus Neoplasms
2
Solid Tumor
2
Prostate Adenocarcinoma
2
Pituitary Neoplasms
2
Pinealoma
2
Osteosarcoma
2
Oligodendroglioma
2
Nerve Sheath Neoplasms
2
Nasopharyngeal Carcinoma
2
Interventions
Doxorubicin
17
Echocardiography
14
Exercise
9
Cyclophosphamide
9
Trastuzumab
8
Dexrazoxane
8
Electrocardiography
7
Razoxane
6
Carvedilol
6
Vincristine
4
Radiotherapy
4
Filgrastim
4
Docetaxel
4
Methotrexate
3
Granulocyte Colony-Stimulating Factor
3
Etoposide
3
Cisplatin
3
Atorvastatin
3
salicylhydroxamic acid
2
sacubitril and valsartan sodium hydrate drug combination
2
empagliflozin
2
dapagliflozin
2
Tablets
2
Social Determinants of Health
2
Silymarin
2
Prednisone
2
Paclitaxel
2
Neoadjuvant Therapy
2
Magnetic Resonance Spectroscopy
2
Leucovorin
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Cardiotoxicity
×
Proton Therapy
×
Clear all
NCT04822077
2021-03-30
PROTHYM
Swedish Lung Cancer Study Group
Phase NA
Recruiting
40 enrolled